---
title: >-
  Real world treatment patterns following the initiation of proprotein
  convertase subtilisin/kexin type 9 antibody inhibitors among adults in the
  United States, 2015-2019.
description: >-
  Explore this publication on real-world evidence: Real world treatment patterns
  following the initiation of proprotein convertase subtilisin/kexin type 9…
date: '2020-01-01'
category: Publications
tags:
  - Cardiovascular
  - ICPE
  - Care
  - Approval & Commercialization
  - 'No'
  - Oral Presentation
  - University of Alabama at Birmingham
canonical_url: >-
  https://www.headwaterscience.com/resources/publications/di-cardiovascular/real-world-treatment-patterns-following-the-initiation-of/
source: Headwater
license: © 2026 Headwater. All rights reserved.
slug: real-world-treatment-patterns-following-the-initiation-of
id: zrwA8rid8CBcFpdmyjuRD
contentType: article
---

## Challenge

Real-world prescribing patterns following PCSK9 inhibitor initiation had not been characterized in a large US patient population, leaving gaps in understanding how these therapies are used in clinical practice.

## Solution

Target RWE researchers analyzed real-world treatment patterns following PCSK9 inhibitor initiation, characterizing rates and predictors of continuation, dose change, switching, and augmentation across commercially insured US patients.